ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,718, issued on July 21.
"Targeted binding agents against B7-H1" was invented by Christophe Queva (Bainbridge Island, Wash.), Michelle Morrow (Cambridge, Great Britain), Scott Hammond (Olney, Md.), Marat Alimzhanov (Wellesley, Mass.), John Babcook (Burnaby, Canada), Ian Foltz (Burnaby, Canada), Jaspal Singh Kang (Surrey, Canada), Laura Sekirov (Burnaby, Canada), Melanie Boyle (Cambridge, Great Britain), Matthieu Chodorge (Cambridge, Great Britain), Ross A. Stewart (Cambridge, Great Britain) and Kathleen Ann Mulgrew (Gaithersburg, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Human monoclonal antibodies directed against B7-H1 and uses of these an...